Back to CAPSTONE INVESTMENT ADVISORS, LLC CAPSTONE INVESTMENT ADVISORS, LLC

TXGTXG
6 quarters

Position history for CAPSTONE INVESTMENT ADVISORS, LLCCAPSTONE INVESTMENT ADVISORS, LLC's holdings in 10x Genomics Inc Class A

CAPSTONE INVESTMENT ADVISORS, LLC previously held 0 shares of TXG (10x Genomics Inc Class A), worth $0 as of 2025-Q4.

Final Value

$0

Final Shares

0

Total Value Change

-$309,235

Total Shares Change

-5,526

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2025-Q4
Latest
Exited
0
-100.0%
$00.0%$16.29
0
2025-Q3
New
29,776
-
$348,0810.0%$11.34
33
2024-Q3
Exited
0
-100.0%
$00.0%$22.67
0
2024-Q2
Decreased
12,677
-21.3%
$246,5680.0%$19.45
0
2024-Q1
Increased
16,115
+191.6%
$604,7960.0%$37.53
39
2023-Q4
New
5,526
-
$309,2350.0%$55.96
32

Other major holders of TXG: BAILLIE GIFFORD & CO, ARK Investment Management LLC, FMR LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used